We have identified a novel FGFR3‐MYC positive feedback loop in bladder tumor cell lines harboring aberrantly activated FGFR3, which may be of clinical relevance, because it was also found in a PDX model harboring an FGFR3 mutation. The gene discussed is MYC; the disease is urinary bladder neoplasm.